open access

Vol 8, No 1 (2007): Practical Diabetology
Review articles (submitted)
Published online: 2007-02-12
Get Citation

Is there a progress in diabetic retinopathy treatment?

Barbara Mirkiewicz-Sieradzka
Diabetologia Praktyczna 2007;8(1):28-34.

open access

Vol 8, No 1 (2007): Practical Diabetology
Review articles (submitted)
Published online: 2007-02-12

Abstract

The aim of this paper was to present the current treatment methods of diabetic retinopathy, both proliferative and nonproliferative. The progress in photocoagulation methods connected with laser photocoagulation and vitrectomy was pointed out. The author presented current pharmacotherapy methods such as growth hormone antagonists, which may lower pathologically elevated levels of vascular endothelial growth factor (VEGF) and insulin like growth factor (IGF-1). By comparison with the older retinopathy treatment methods, the author presented the huge progress in the treatment of this chronic and serious complication of diabetes.

Abstract

The aim of this paper was to present the current treatment methods of diabetic retinopathy, both proliferative and nonproliferative. The progress in photocoagulation methods connected with laser photocoagulation and vitrectomy was pointed out. The author presented current pharmacotherapy methods such as growth hormone antagonists, which may lower pathologically elevated levels of vascular endothelial growth factor (VEGF) and insulin like growth factor (IGF-1). By comparison with the older retinopathy treatment methods, the author presented the huge progress in the treatment of this chronic and serious complication of diabetes.
Get Citation

Keywords

diabetic retinopathy; treatment; photocoagulation; vitrectomy; growth hormone antagonists; risk factors

About this article
Title

Is there a progress in diabetic retinopathy treatment?

Journal

Clinical Diabetology

Issue

Vol 8, No 1 (2007): Practical Diabetology

Pages

28-34

Published online

2007-02-12

Bibliographic record

Diabetologia Praktyczna 2007;8(1):28-34.

Keywords

diabetic retinopathy
treatment
photocoagulation
vitrectomy
growth hormone antagonists
risk factors

Authors

Barbara Mirkiewicz-Sieradzka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl